Ethypharm UK Ltd
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- VENTRA gastro-resistant capsule, hard 20 mg
- VENTRA gastro-resistant capsule, hard 40 mg
- C01 - Terapia cardíaca
- NYZAMAC SR prolonged-release capsule, hard 40 mg
- NYZAMAC SR prolonged-release capsule, hard 50 mg
- NYZAMAC SR prolonged-release capsule, hard 60 mg
- C08 - Bloqueantes del canal de calcio
- ANGITIL SR prolonged-release capsule, hard 120 mg
- ANGITIL SR prolonged-release capsule, hard 180 mg
- ANGITIL SR prolonged-release capsule, hard 90 mg
- ANGITIL XL prolonged-release capsule, hard 240 mg
- ANGITIL XL prolonged-release capsule, hard 300 mg
- N02 - Analgésicos
- MAXITRAM SR prolonged-release capsule, hard 100 mg
- MAXITRAM SR prolonged-release capsule, hard 150 mg
- MAXITRAM SR prolonged-release capsule, hard 200 mg
- MAXITRAM SR prolonged-release capsule, hard 50 mg
- ZOMORPH prolonged-release capsule, hard 10 mg
- ZOMORPH prolonged-release capsule, hard 100 mg
- ZOMORPH prolonged-release capsule, hard 200 mg
- ZOMORPH prolonged-release capsule, hard 30 mg
- ZOMORPH prolonged-release capsule, hard 60 mg
- N06 - Psicoanalépticos
- VENLALIC prolonged-release tablet 150 mg
- VENLALIC prolonged-release tablet 225 mg
- VENLALIC prolonged-release tablet 300 mg
- VENLALIC prolonged-release tablet 37.5 mg
- VENLALIC prolonged-release tablet 75 mg
- XAGGITIN XL prolonged-release tablet 18 mg
- XAGGITIN XL prolonged-release tablet 27 mg
- XAGGITIN XL prolonged-release tablet 36 mg
- XAGGITIN XL prolonged-release tablet 54 mg